← Leaderboards
Laquita M Jones
Cincinnati Childrens Hosp Med Ctr
$786,537
Attributed
$786,537
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.2K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$786,537 · 1
By mechanism
K08$786,537 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Mohammad Azam$5,839,846
- Biplab Dasgupta$8,405,387
- Daniel Starczynowski$17,551,895
- H Leighton Grimes$23,205,568
- Chandrashekhar Pasare$12,696,005
Others in their field
Other Rising Stars on “Acute Myelocytic Leukemia”
- Michael E. Roth · Public Health Institute$8,303,012
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myelocytic LeukemiaAcute Myeloid Leukemia CellAdaptor Signaling ProteinAffectAffinityApplications GrantsBindingBinding SitesBiologicalBiologyCancer TypeCell LineCell ProliferationCell SurvivalChemotherapyClustered Regularly Interspaced Short Palindromic RepeatsCodon NucleotidesCombinatorialCombined Modality TherapyCrispr ScreenDependenceDrug DevelopmentEngineeringAcute Leukemia
Grant awards (3)
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML$262,179
K08 · FY2025 · CA · contact PI
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML$262,179
K08 · FY2024 · CA · contact PI
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML$262,179
K08 · FY2023 · CA · contact PI